Predictive Analysis of Non-Cardiac Drug-Induced QTc Interval Prolongation: A Cross-Sectional Study.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 85, doi. 10.2147/CPAA.S509476
- By:
- Publication type:
- Article
Works matching IS 11791438 AND DT 2025 AND VI 17
Results: 8
1
2
Novel Therapies in Primary Central Nervous System Lymphoma.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 97, doi. 10.2147/CPAA.S501065
- By:
- Publication type:
- Article
3
Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 49, doi. 10.2147/CPAA.S502272
- By:
- Publication type:
- Article
4
Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 29, doi. 10.2147/CPAA.S513282
- By:
- Publication type:
- Article
5
A Case Report of Sustained Cytokine Release Syndrome Due to Glofitamab and Literature Review.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 79, doi. 10.2147/CPAA.S515122
- By:
- Publication type:
- Article
6
Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab).
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 25, doi. 10.2147/CPAA.S512508
- By:
- Publication type:
- Article
7
The Therapeutic Effects of Curcumin on Oral Disease: A Systematic Review.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 13, doi. 10.2147/CPAA.S506396
- By:
- Publication type:
- Article
8
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.
- Published in:
- Clinical Pharmacology, 2025, v. 17, p. 1, doi. 10.2147/CPAA.S493750
- By:
- Publication type:
- Article